Single-agent PLX51107 and anti–PD-L1 produced a moderate reduction in tumor volume, but the combination significantly reduced tumor growth compared with either agent alone (Figure 6C and Supplemental Figure 13A; P < 0.01). This evidence concerns the gene CD274 and neoplasm.